Citation Impact
Citing Papers
FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study
2003 Standout
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
2000 Standout
Colorectal cancer statistics, 2014
2014 Standout
Guidelines for the welfare and use of animals in cancer research
2010 Standout
Synthetic lethality: a framework for the development of wiser cancer therapeutics
2009 StandoutNobel
Metagenomic analysis of gut microbiota modulatory effects of jujube (Ziziphus jujuba Mill.) polysaccharides in a colorectal cancer mouse model
2019 Standout
Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers.
1998
The Concept of Synthetic Lethality in the Context of Anticancer Therapy
2005 StandoutNobel
From traditional Chinese medicine to rational cancer therapy
2007 Standout
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Phase II Trial of Intravenous CI-980 (NSC 370147) in Patients with Metastatic Colorectal Carcinoma
1997
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
2004 Standout
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
2009 Standout
Phase II trial of irinotecan in patients with metastatic colorectal carcinoma.
1997
Dose-escalation and pharmacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancer.
1997
Safety and antitumor activity of recombinant soluble Apo2 ligand
1999 Standout
Natural products for treating colorectal cancer: A mechanistic review
2019
Colorectal cancer
2019 Standout
Chemotherapy and the war on cancer
2005 Standout
Gut microbiota modulation of chemotherapy efficacy and toxicity
2017 Standout
Phase I clinical and pharmacokinetic study of irinotecan, fluorouracil, and leucovorin in patients with advanced solid tumors.
1996
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates
2009 Standout
Clinical applications of the camptothecins
1998
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Multiple DNA repair mechanisms and alkylator resistance in the human medulloblastoma cell line D-283 Med (4-HCR)
1999 StandoutNobel
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Sensitivity to CPT-11 of xenografted human colorectal cancers as a function of microsatellite instability and p53 status
2000
Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders
2004 Standout
Topoisomerase I inhibitors: Review and update
1997
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
2000 Standout
Natural compounds for cancer treatment and prevention
2009 Standout
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
2000 Standout
A Phase II Trial of Homoharringtonine and Caracemide in the Treatment of Patients with Advanced Large Bowel Cancer
1999
New drugs in the treatment of colorectal carcinoma
1998
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
2004 Standout
Plants and the central nervous system
2003 Standout
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
2020 Standout
A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer
2003 Standout
Phase II trial of CPT-11 in patients with advanced pancreatic cancer, an EORTC early clinical trials group study
1995
Perspectives in cancer chemotherapy
2001
A multicenter, Phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma
1999
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
An Update on Hepatic Arterial Infusion Chemotherapy for Colorectal Cancer
2003
Molecular Modeling Studies of the DNA−Topoisomerase I Ternary Cleavable Complex with Camptothecin
1998 StandoutNobel
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
The Role of Plant-Derived Drugs and Herbal Medicines in Healthcare
1997
Irinotecan in the Treatment of Colorectal Cancer: Clinical Overview
2001
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Recommended Guidelines for the Treatment of Cancer Treatment-Induced Diarrhea
2004
Combination of Oxaliplatin Plus Irinotecan in Patients With Gastrointestinal Tumors: Results of Two Independent Phase I Studies With Pharmacokinetics
1999
Irinotecan Fluorouracil Plus Leucovorin Is Not Superior to Fluorouracil Plus Leucovorin Alone As Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803
2007
Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer
2007 Standout
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
2003 Standout
Chemotherapy for the Treatment of Patients with Metastatic Colorectal Cancer: An Overview
1997
Prevention of chemotherapy and radiation toxicity with glutamine
2003
Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer
2003 Standout
Mathematics – Key Technology for the Future
2008 Standout
Irinotecan Combined With Bolus Fluorouracil, Continuous Infusion Fluorouracil, and High-Dose Leucovorin Every Two Weeks (LV5FU2 Regimen): A Clinical Dose-Finding and Pharmacokinetic Study in Patients With Pretreated Metastatic Colorectal Cancer
1999
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
2007 Standout
Evolving Treatment of Advanced Colon Cancer
2009
Trends in the Aggressiveness of Cancer Care Near the End of Life
2004 Standout
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
2010 Standout
Phase II Trial of Irinotecan in Patients With Metastatic Epithelial Ovarian Cancer or Peritoneal Cancer
2003
Phase I Study of a Weekly Schedule of Irinotecan, High-Dose Leucovorin, and Infusional Fluorouracil as First-Line Chemotherapy in Patients With Advanced Colorectal Cancer
1999
Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents)
2000 Standout
Role of E2F-1 in chemosensitivity.
1998
Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis From Colorectal Cancer: A Multi-Institutional Study
2004 Standout
Irinotecan Plus Fluorouracil/Leucovorin for Metastatic Colorectal Cancer: A New Survival Standard
2001
DNA Topoisomerases: Structure, Function, and Mechanism
2001 Standout
Works of Stephanie Pulliam being referenced
Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma.
1994
Irinotecan is an active agent in untreated patients with metastatic colorectal cancer.
1996